Killingsworth lifts UC San Diego over CS Northridge 72-64
Published Jan. 2, 2022 12:41 a.m. ET
Associated Press
SAN DIEGO (AP) — Jake Killingsworth had a career-high 20 points plus 10 rebounds as UC San Diego defeated Cal State Northridge 72-64 on Saturday night.
Killingsworth hit 5 of 7 3-pointers.
Bryce Pope had 18 points for UC San Diego (8-5, 2-0 Big West Conference), which earned its sixth consecutive home victory. Toni Rocak added 14 points. Jake Kosakowski had 11 points.
Atin Wright had 16 points for the Matadors (4-8, 0-1). Elijah Hardy added 13 points. Brendan Harrick had 11 points and 10 rebounds.
___
For more AP college basketball coverage:
___
This was generated by Automated Insights,
share
recommended
The New-Look Pac-12 Unveiled a New-Look Logo
2026 College Basketball Transfer Portal Tracker: Juke Harris Transfers To Tennessee
Top 25 college athletes with highest NIL valuations
2026 NBA Draft Declarations Tracker: Duke's Cameron Boozer Declares
Cooper Flagg talks NIL, Finances and New Partnership
Who are the 10 best Duke basketball players of all time?
Top 10 men's college basketball players with highest NIL valuations
Ranking the Best Landing Spots For Top Men's College Basketball Transfers
Men's College Basketball Rankings: Illinois, Duke Highlight Way-Too-Early Top 25
Item 1 of 3
recommended
The New-Look Pac-12 Unveiled a New-Look Logo
2026 College Basketball Transfer Portal Tracker: Juke Harris Transfers To Tennessee
Top 25 college athletes with highest NIL valuations
2026 NBA Draft Declarations Tracker: Duke's Cameron Boozer Declares
Cooper Flagg talks NIL, Finances and New Partnership
Who are the 10 best Duke basketball players of all time?
Top 10 men's college basketball players with highest NIL valuations
Ranking the Best Landing Spots For Top Men's College Basketball Transfers
Men's College Basketball Rankings: Illinois, Duke Highlight Way-Too-Early Top 25
Item 1 of 3
FOX SPORTS™, SPEED™, SPEED.COM™ & © 2026 Fox Media LLC
and Fox Sports Interactive Media, LLC. All rights reserved. Use of this
website (including any and all parts and components) constitutes your
acceptance of these
Terms of Use and Privacy Policy | Advertising Choices |
Your Privacy Choices | Closed Captioning
